AstraZeneca PLC (NYSE:AZN) under comprehensive financial analysis presented as an active mover. Shares plunged -1.42% to trade at $39.51 in recent trading session. The firm has floated short ratio of 0.42%, hold to candle to sentiment indicator of Short Ratio, which was 2.69.
AZN has noticeable price to earnings growth ratio of 2.96, which find it more attractive on the other stock that has lower PEG and vice versa. It is useful, but ultimately financial modeling is the best way to account for all aspects of a firm’s growth profile when performing a valuation. Building a Discounted Cash Flow (DCF) model typically takes into account about 5 years of forecasted growth, plus a terminal value, to arrive at the net present value of the business. The firm price to earnings ratio calculated as 37.03. Several investors think that a company with a high P/E is overpriced, as well as they might be correct. A high P/E can be a signal that traders have pushed a stock’s price beyond the point where any reasonable near-term growth is probable. The co stands at price to sale ratio of 4.48 that signifies the value placed on each dollar of a firm’s sales or incomes; it is most relevant ratio to compare companies in similar sector. It has price to book ratio of 7.92, which gauges the market price of a share over its book value.
AstraZeneca PLC (NYSE:AZN) need to consider for profitability analysis, the firm has profit margin of positive 12.00% to find consistent trends in a firm’s earnings. A corporation’s profit is calculated at three
levels on its income statement, beginning with the most basic gross profit and building up to the most comprehensive net profit. Between these two lies operating profit. Gross profit margin and operating profit margin calculated as 80.01% and 14.70% respectively. AZN has returns on investment of 13.30%. The returns on assets were 4.20% that gives an idea about how efficient management is at using its assets to generate earnings. It has returns on equity of 19.70%, which is measuring profitability by disclosing how much profit generates by AZN with the shareholders’ money.
The firm attains analyst recommendation of 1.80 on scale of 1-5. The co has price volatility of 1.03% for a week and 0.90% for a month. Narrow down focus to firm performance, its weekly performance was -0.53% and monthly performance was 5.56%. The stock price of AZN is moving up from its 20 days moving average with 3.31% and isolated positively from 50 days moving average with 2.80%.
AstraZeneca PLC (NYSE:AZN) current ratio calculated as 0.70, this value is acceptable if it lies in 1.3% to 3%. The firm show how many times over the firm can pay its current debt obligations based on its assets. This is obviously a good position for the firm to be in. It can meet its short-term debt obligations with no stress. But it varies industry to industry. To strengthen these views, active industry firm has Quick Ratio of 0.50, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 1.56, sometimes it remain same with long term debt to equity ratio.